Home / Al-Razi Medical Co. / 2025 Annual Results

Al-Razi Medical Co. 2025 Annual Results

Revenue

SAR 74M

Net Profit

SAR 819K

EPS

SAR 0.54

Operating Cash Flow

SAR 6M

Al-Razi Medical Co. (9572) reported full year 2025 revenue of SAR 74M, up 21.2% from SAR 61M in 2024. Net profit came in at SAR 819K, up 366.0% year on year. Earnings per share were SAR 0.54. The company generated SAR 6M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 7.11 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 7.11.

Key Financial Metrics

Metric	2025	2024
Revenue	SAR 74M	SAR 61M
Net Profit	SAR 819K	SAR 176K
Net Margin	1.1%	0.3%
ROE	3.5%	0.8%
EPS	SAR 0.54	SAR 0.12
Total Assets	SAR 53M	SAR 41M
Total Equity	SAR 24M	SAR 23M
Total Liabilities	SAR 30M	SAR 18M
Operating Cash Flow	SAR 6M	SAR 5M

Year on Year Comparison

Revenue increased by 21.2% compared to 2024. Net profit increased by 366.0%. Both revenue and profit grew — indicating expanding business.

View full company profile →

View all years:

2025 2024 2023

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-04-02.